Submit Manuscript now
Impact Factor 2.6

Month: March 2021

Endoscopic Bougie Dilation Combined with Bleomycin Injection is Effective for Benign Esophageal Anastomotic Stricture

Leave a Comment / Issue 1 Articles, Volume 6 / By

1. Abstract 1.1. Background/Aim: The longstanding effect of the existing treatments have been limited for managing benign postoperative esophageal anastomotic stricture. This study was conducted to ex- plore the safety and efficacy of endoscopic dilation combined with bleomycin for the treatment of benign anastomotic esophageal stric- ture. http://dx.doi.org/10.47829/JJGH.2021.6103

PET/MRI: A Promising Tool for Detecting Cardiac Neuroendocrine Tumor Metastasis

Leave a Comment / Issue 1 Articles, Volume 6 / By

1. Abstract Neuroendocrine Tumors (NET) staging, including metastasis detec- tion, will affect the management and the prognosis of the disease. MRI imaging and somatostatin receptor [SSTR]-targeted PET ap- pear complementary for metastasis detection with a higher sensitivity of PET for lymph node and lung metastases identification and a higher sensitivity of MRI for liver metastases …

PET/MRI: A Promising Tool for Detecting Cardiac Neuroendocrine Tumor Metastasis Read More »

Which Laparoscopic Sleeve Gastrectomies Convert into Roux En Y Gastric Bypass? A Prospective Monocentric Study About 50 Patients

Leave a Comment / Issue 1 Articles, Volume 6 / By

1. Abstract 1.1. Background: Despite promising short-term results, revision from Sleeve Gastrectomy (SG) to Roux-en-Y gastric bypass (RYGBP) can be required due to either inadequate weight loss or weight regain (IWL/WR), or de novo complications, such as gastroesophageal reflux disease (GERD) or gastric stenosis. 1.2. Objectives: To report surgical outcomes in converting SG to RYGBP …

Which Laparoscopic Sleeve Gastrectomies Convert into Roux En Y Gastric Bypass? A Prospective Monocentric Study About 50 Patients Read More »

What Our Author Say's

I am glad that I found this platform. It was easy to get my research published and I was guided at every step. I highly recommend them.
Shuang-Qin Yi
am grateful to the Japanese Journal of Gastroenterology and Hepatology for helping me with my research and publishing it. Looking forward to more work with them.
Makki Fayadh
It has been a pleasure working with the Japanese Journal of Gastroenterology and Hepatology. They have been amazing in helping me with my manuscript
Han Min
I am glad that I submitted my manuscript here. They helped me make necessary edits and published the best version of it. I highly recommend them.
Sadaf Saleem

FAQ's About Jajgastrohepto

The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.

For Detailed quotations reach out submission@jajogh.jp

It depends on the length of the manuscript and the reviews and edits needed.

We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.

A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.

Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.

*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.

Copyright 2018-2024 All Rights Reserved.